Literature DB >> 22428468

Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.

S Shelbaya1, H Amer, S Seddik, A A Allah, I M Sabry, T Mohamed, M El Mosely.   

Abstract

BACKGROUND: Diabetes Mellitus (DM) is becoming an increasingly common disease which is the leading cause of chronic renal failure. The pathogenesis of diabetic nephropathy is still a matter of debate. There are conflicting results regarding the relation of C reactive protein (CRP), interleukin-6 (IL-6) and diabetic nephropathy in type 1 diabetes.
OBJECTIVES: This study was aiming to determine the association between higly sensitive (Hs)-CRP and IL6 with nephropathy in a sample of type 1 diabetic Egyptian patients.
MATERIALS AND METHODS: The study was conducted on forty type-1 diabetic patients (Group I), who subdivided into three subgroups according to their urine albumin excretion rate (AER); Group IA: 10 patients with AER <20 microg/min, Group IB: 15 patients with AER ranges from 20-200 microg/min. Group IC: 15 patients with AER is > 200 microg/min and 10 healthy subjects as a control (Group II).
RESULTS: There were high statistical significant difference (p < 0.001) between group I with group II regarding HsCRP (4.39 +/- 1.94, 1.32 +/- 0.39), and IL-6 (2.82 +/- 0.76, 1.95 +/- 0.35). In group I, we found a positive significant correlation (p < 0 .001) between UAE and levels of Hs-CRP (r = 0.927), and IL-6 (r = 0.838), respectively. Also, a positive significant correlation between Hs-CRP and IL-6 (r = 0.728, p < 0.001) was found. Fasting plasma glucose (FPG) level and HbA1c showed a significant positive correlation (p < 0.001) with Hs-CRP (r = 0.531) (r = 0.750), and IL-6 (r = 0. 490) (r = 0.680) respectively.
CONCLUSION: Hs-CRP and IL-6 are sensitive markers for diabetic nephropathy predicting its progression and severity in type 1 diabetics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428468

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

Review 1.  Inflammation: therapeutic targets for diabetic neuropathy.

Authors:  Jiyin Zhou; Shiwen Zhou
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

2.  Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant.

Authors:  Subhadra C Gunawardana; David W Piston
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

3.  Changes in salivary biomarkers associated with periodontitis and diabetic neuropathy in individuals with type 1 diabetes.

Authors:  Larissa Steigmann; Shogo Maekawa; Frederic Kauffmann; Jacob Reiss; Ashley Cornett; James Sugai; Julian Venegas; Xudong Fan; Yuying Xie; William V Giannobile; Rodica Pop-Busui; Isabelle M A Lombaert
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

Review 4.  Novel biomarkers for prognosticating diabetic kidney disease progression.

Authors:  Shilna Muttickal Swaminathan; Indu Ramachandra Rao; Srinivas Vinayak Shenoy; Attur Ravindra Prabhu; Pooja Basthi Mohan; Dharshan Rangaswamy; Mohan V Bhojaraja; Shivashankara Kaniyoor Nagri; Shankar Prasad Nagaraju
Journal:  Int Urol Nephrol       Date:  2022-10-22       Impact factor: 2.266

5.  Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic Kidney.

Authors:  Ahmed Amir Radwan Sayed
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

6.  The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats.

Authors:  Abdulrahman L Al-Malki; Haddad A El Rabey
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

7.  Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.

Authors:  Khalid Al-Rubeaan; Khalid Siddiqui; Mohammed A Al-Ghonaim; Amira M Youssef; Ahmed H Al-Sharqawi; Dhekra AlNaqeb
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

8.  The serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.

Authors:  Monika Ryba-Stanisławowska; Maria Skrzypkowska; Jolanta Myśliwska; Małgorzata Myśliwiec
Journal:  Mediators Inflamm       Date:  2013-02-21       Impact factor: 4.711

9.  IVS1 -397T>C estrogen receptor α polymorphism is associated with low-grade systemic inflammatory response in type 1 diabetic girls.

Authors:  Monika Ryba-Stanisławowska; Karolina Rybarczyk-Kapturska; Agnieszka Brandt; Małgorzata Myśliwiec; Jolanta Myśliwska
Journal:  Mediators Inflamm       Date:  2014-01-02       Impact factor: 4.711

10.  Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.

Authors:  Caroline Pereira Domingueti; Rodrigo Bastos Fóscolo; Janice Sepúlveda Reis; Fernanda Magalhães Freire Campos; Luci Maria S Dusse; Maria das Graças Carvalho; Karina Braga Gomes; Ana Paula Fernandes
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.